Baxter Gross Profit 2010-2024 | BAX
Baxter annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Baxter gross profit for the quarter ending September 30, 2024 was $1.033B, a 2.18% decline year-over-year.
- Baxter gross profit for the twelve months ending September 30, 2024 was $5.384B, a 13.49% increase year-over-year.
- Baxter annual gross profit for 2023 was $4.975B, a 1.8% decline from 2022.
- Baxter annual gross profit for 2022 was $5.066B, a 7.33% increase from 2021.
- Baxter annual gross profit for 2021 was $4.72B, a 2.9% increase from 2020.
| Baxter Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $4,975 |
| 2022 | $5,066 |
| 2021 | $4,720 |
| 2020 | $4,587 |
| 2019 | $4,761 |
| 2018 | $4,759 |
| 2017 | $4,474 |
| 2016 | $4,116 |
| 2015 | $4,146 |
| 2014 | $4,581 |
| 2013 | $4,162 |
| 2012 | $7,134 |
| 2011 | $7,046 |
| 2010 | $5,958 |
| 2009 | $6,525 |
| Baxter Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,033 |
| 2024-06-30 | $1,431 |
| 2024-03-31 | $1,387 |
| 2023-12-31 | $1,533 |
| 2023-09-30 | $1,056 |
| 2023-06-30 | $1,111 |
| 2023-03-31 | $1,275 |
| 2022-12-31 | $1,302 |
| 2022-09-30 | $1,045 |
| 2022-06-30 | $1,371 |
| 2022-03-31 | $1,348 |
| 2021-12-31 | $1,021 |
| 2021-09-30 | $1,321 |
| 2021-06-30 | $1,233 |
| 2021-03-31 | $1,145 |
| 2020-12-31 | $1,191 |
| 2020-09-30 | $1,195 |
| 2020-06-30 | $1,038 |
| 2020-03-31 | $1,163 |
| 2019-12-31 | $1,298 |
| 2019-09-30 | $1,230 |
| 2019-06-30 | $1,153 |
| 2019-03-31 | $1,080 |
| 2018-12-31 | $1,174 |
| 2018-09-30 | $1,232 |
| 2018-06-30 | $1,239 |
| 2018-03-31 | $1,114 |
| 2017-12-31 | $1,168 |
| 2017-09-30 | $1,130 |
| 2017-06-30 | $1,132 |
| 2017-03-31 | $1,044 |
| 2016-12-31 | $1,108 |
| 2016-09-30 | $1,071 |
| 2016-06-30 | $972 |
| 2016-03-31 | $965 |
| 2015-12-31 | $1,072 |
| 2015-09-30 | $1,034 |
| 2015-06-30 | $1,021 |
| 2015-03-31 | $1,019 |
| 2014-12-31 | $1,207 |
| 2014-09-30 | $1,193 |
| 2014-06-30 | $1,969 |
| 2014-03-31 | $1,891 |
| 2013-12-31 | $1,996 |
| 2013-09-30 | $1,906 |
| 2013-06-30 | $1,939 |
| 2013-03-31 | $1,756 |
| 2012-12-31 | $1,738 |
| 2012-09-30 | $1,810 |
| 2012-06-30 | $1,872 |
| 2012-03-31 | $1,714 |
| 2011-12-31 | $1,765 |
| 2011-09-30 | $1,771 |
| 2011-06-30 | $1,835 |
| 2011-03-31 | $1,675 |
| 2010-12-31 | $1,618 |
| 2010-09-30 | $1,659 |
| 2010-06-30 | $1,638 |
| 2010-03-31 | $1,043 |
| 2009-12-31 | $1,767 |
| 2009-09-30 | $1,632 |
| 2009-06-30 | $1,638 |
| 2009-03-31 | $1,488 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.074B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Medtronic (MDT) | Ireland | $112.764B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| Surmodics (SRDX) | United States | $0.492B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Zynex (ZYXI) | United States | $0.236B | 49.40 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |